Study and intervention group | n | Exercise prescription | |
---|---|---|---|
STRRIDE I | Â | Â | Â |
High Amount/Vigorous Intensity | 64 | 23 KKW | 65–80% peak V̇O2 |
Low Amount/Vigorous Intensity | 58 | 14 KKW | 65–80% peak V̇O2 |
Low Amount/Moderate Intensity | 57 | 14 KKW | 40–55% peak V̇O2 |
STRRIDE AT/RT | Â | Â | Â |
Aerobic Training (Low Amount/Vigorous Intensity) | 47 | 14 KKW | 65–80% peak V̇O2 |
Resistance Training | 51 | 3 days/week, 3 sets/day, 8–12 reps of 8 exercises |  |
Aerobic + Resistance Training | 44 | 14 KKW at 65–80% peak V̇O2 + 3 days/week, 3 sets/day, 8–12 reps of 8 exercises |  |
STRRIDE-PD | Â | Â | Â |
High Amount/Vigorous Intensity | 38 | 16 KKW | 65–80% V̇O2 reserve |
High Amount/Moderate Intensity | 40 | 16 KKW | 40–55% V̇O2 reserve |
Low Amount/Moderate Intensity | 35 | 10 KKW | 40–55% V̇O2 reserve |
Clinical Lifestyle Intervention | 37 | 10 KKW at 40–55% V̇O2 reserve + caloric restriction to reduce body weight by 7% |  |